rs1363996930

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001164507.2(NEB):​c.12790A>G​(p.Met4264Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 8)
Exomes 𝑓: 0.000026 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

NEB
NM_001164507.2 missense

Scores

16

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: -1.25

Publications

0 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
  • nemaline myopathy 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.095669955).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBNM_001164507.2 linkc.12790A>G p.Met4264Val missense_variant Exon 85 of 182 ENST00000427231.7 NP_001157979.2
NEBNM_001164508.2 linkc.12790A>G p.Met4264Val missense_variant Exon 85 of 182 ENST00000397345.8 NP_001157980.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBENST00000397345.8 linkc.12790A>G p.Met4264Val missense_variant Exon 85 of 182 5 NM_001164508.2 ENSP00000380505.3
NEBENST00000427231.7 linkc.12790A>G p.Met4264Val missense_variant Exon 85 of 182 5 NM_001164507.2 ENSP00000416578.2
NEBENST00000409198.5 linkc.11601+4980A>G intron_variant Intron 78 of 149 5 ENSP00000386259.1

Frequencies

GnomAD3 genomes
Cov.:
8
GnomAD2 exomes
AF:
0.0000385
AC:
2
AN:
51946
AF XY:
0.0000383
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000974
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000263
AC:
13
AN:
495078
Hom.:
0
Cov.:
6
AF XY:
0.0000386
AC XY:
10
AN XY:
259056
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
11296
American (AMR)
AF:
0.00
AC:
0
AN:
18906
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12792
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24124
South Asian (SAS)
AF:
0.00
AC:
0
AN:
45204
European-Finnish (FIN)
AF:
0.0000409
AC:
1
AN:
24466
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1830
European-Non Finnish (NFE)
AF:
0.0000332
AC:
11
AN:
331444
Other (OTH)
AF:
0.0000400
AC:
1
AN:
25016
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000315182), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.379
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
8
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Nemaline myopathy 2 Uncertain:2
Aug 14, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant occurs in a region of NEB (Exons 82-105) consisting of three highly homologous 8-exon repeat units (exons 82-89, exons 90-97, exons 98-105). Sequence variants in this region can be detected, but this assay cannot determine which of the three repeat units is affected, and zygosity is often ambiguous. All variants in this region are reported relative to the exon 82-89 repeat. This variant has not been reported in the literature in individuals with NEB-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Nov 11, 2019
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.23
DANN
Benign
0.30
DEOGEN2
Benign
0.0020
.;T;.;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.059
N
LIST_S2
Benign
0.67
T;T;T;.;.
M_CAP
Benign
0.0062
T
MetaRNN
Benign
0.096
T;T;T;T;T
MetaSVM
Benign
-0.82
T
PhyloP100
-1.3
PROVEAN
Benign
0.83
N;.;N;.;.
REVEL
Benign
0.017
Sift
Benign
1.0
T;.;T;.;.
Sift4G
Benign
1.0
T;T;T;T;T
Vest4
0.20
MutPred
0.41
Loss of catalytic residue at M4264 (P = 0.0863);Loss of catalytic residue at M4264 (P = 0.0863);Loss of catalytic residue at M4264 (P = 0.0863);Loss of catalytic residue at M4264 (P = 0.0863);Loss of catalytic residue at M4264 (P = 0.0863);
MVP
0.088
MPC
0.052
ClinPred
0.032
T
GERP RS
0.15
gMVP
0.00044
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1363996930; hg19: chr2-152461343; API